These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 25625172)
21. Promising leads opening up with vaccine research. One route involves neutralizing antibodies. AIDS Alert; 2009 Nov; 24(11):123-5. PubMed ID: 19960606 [No Abstract] [Full Text] [Related]
22. AIDS 1997. Vaccines and immunology: overview. Hu S; Norrby E AIDS; 1997; 11 Suppl A():S85-6. PubMed ID: 9451971 [No Abstract] [Full Text] [Related]
23. A brief history of the global effort to develop a preventive HIV vaccine. Esparza J Vaccine; 2013 Aug; 31(35):3502-18. PubMed ID: 23707164 [TBL] [Abstract][Full Text] [Related]
24. DNA vaccines expressing soluble CD4-envelope proteins fused to C3d elicit cross-reactive neutralizing antibodies to HIV-1. Bower JF; Green TD; Ross TM Virology; 2004 Oct; 328(2):292-300. PubMed ID: 15464849 [TBL] [Abstract][Full Text] [Related]
25. Current progress in HIV vaccines. Westblom TU; Belshe RB; Gorse GJ Mo Med; 1991 Nov; 88(11):762-5. PubMed ID: 1805131 [No Abstract] [Full Text] [Related]
27. (Un)risky business: adolescents and HIV prevention trials. Philpott S Am J Bioeth; 2011 Jun; 11(6):17-9. PubMed ID: 21678207 [No Abstract] [Full Text] [Related]
28. AIDS research. Novel antibody response may explain HIV vaccine success. Cohen J Science; 2011 Sep; 333(6049):1560. PubMed ID: 21921167 [No Abstract] [Full Text] [Related]
29. As antibody findings mount, what comes next? Interview by Kristen Jill Kresge and Regina McEnery. Burton D; Mascola J; Michael N; Overbaugh J IAVI Rep; 2011; 15(1):4-7. PubMed ID: 21449503 [No Abstract] [Full Text] [Related]
30. Moving on from the failed HIV vaccine clinical trial. Adepoju P Lancet HIV; 2020 Mar; 7(3):e161. PubMed ID: 32142713 [No Abstract] [Full Text] [Related]
31. Combo of two HIV vaccines fails its big test. Cohen J Science; 2020 Feb; 367(6478):611-612. PubMed ID: 32029605 [No Abstract] [Full Text] [Related]
35. [Development of a vaccine against HIV: is this aim accomplishable?]. Wagner R; Asbach B MMW Fortschr Med; 2013 Jun; 155 Suppl 1():36-9. PubMed ID: 23961653 [No Abstract] [Full Text] [Related]
36. [Prospects for vaccine development against HIV infection]. Kurth R; Binninger D; Ennen J; Denner J; Hartung S; Norley S Verh Dtsch Ges Inn Med; 1991; 97():394-402. PubMed ID: 1808921 [No Abstract] [Full Text] [Related]
37. HIV-1 Env antibodies: are we in a bind or going blind? Moore JP Nat Med; 2012 Mar; 18(3):346-7; author reply 347-8. PubMed ID: 22395694 [No Abstract] [Full Text] [Related]
38. First candidate enrolled in new HIV vaccine trial. Expert Rev Vaccines; 2003 Dec; 2(6):732-3. PubMed ID: 15278999 [No Abstract] [Full Text] [Related]
39. [How far away is the first anti-HIV vaccine?]. Bürk RR Fortschr Med; 1994 Mar; 112(7):61-2. PubMed ID: 8175095 [No Abstract] [Full Text] [Related]
40. Getting it right early. Newspaper Article. Noble S IAVI Rep; 2007; 11(5):7-8. PubMed ID: 20214012 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]